Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s OTC Monograph Division Head Recognizes Need To Speed Process

Executive Summary

Addressing industry stakeholders as a member of a CHPA conference panel, FDA’s OTC monograph division chief Scott Furness says the agency shares companies’ frustration with the sluggish pace of monograph finalization. However, he shares some good news on time and extent applications.


Related Content

U.S. Sunscreen Group Suggests User Fees To Expedite Ingredient Reviews
OTC Firms Should Improve Monograph Compliance, Registration – CDER

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts